Clinical Trial Update: Efficacy and Safety of Ciclesonide Nasal Spray in Participants With Seasonal Allergic Rhinitis (SAR) in Russia [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of ciclesonide nasal spray in participants with seasonal allergic rhinitis in Russia. The study results have be…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• Ciclesonide nasal spray (ciclesonide)

Snippet

Sponsor: AstraZeneca | Conditions: Seasonal Allergic Rhinitis | Phase 3 | Status: COMPLETED | Results posted: 2016-10-06